International Association For The Study Of Lung Cancer
- Assets
- $25.4m
- Revenue
- $11.6m
- Investments
- $8.2m
- Employees
- 35
- Location
- Denver, CO
- Founding
- 02/2007
- Data as of
- 12/2022
- EIN
- 20-0499338
Organization Overview
International Association For The Study Of Lung Cancer is located in Denver, CO. The organization was established in 2007. According to its NTEE Classification (S41) the organization is classified as: Chambers of Commerce & Business Leagues, under the broad grouping of Community Improvement & Capacity Building and related organizations. As of 12/2022, International Association For The Study Of Lung Cancer employed 35 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. International Association For The Study Of Lung Cancer is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, International Association For The Study Of Lung Cancer generated $11.6m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 7 years, the organization has seen revenues fall by an average of (3.8%) each year. All expenses for the organization totaled $14.6m during the year ending 12/2022. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
TO PROMOTE THE STUDY OF THE ETIOLOGY, EPIDEMIOLOGY, PREVENTION, DIAGNOSIS, TREATMENT AND ALL OTHER ASPECTS OF LUNG CANCER AND OTHER THORACIC MALIGNANCIES.TO PROVIDE EDUCATION AND INFORMATION ABOUT LUNG CANCER AND OTHER THORACIC MALIGNANCIES TO IASLC MEMBERS, TO THE MEDICAL COMMUNITY AT LARGE, AND TO THE PUBLIC.TO USE ALL AVAILABLE MEANS TO ELIMINATE LUNG CANCER AND OTHER THORACIC MALIGNANCIES AS A HEALTH THREAT FOR THE INDIVIDUAL PATIENT AND THROUGHOUT THE WORLD.
Describe the Organization's Program Activity:
Part 3 - Line 4a
MEMBERSHIPS AND OTHER PROGRAMS TO ADVANCE THE STUDY OF LUNG CANCER
PUBLICATIONS AND SCIENTIFIC PROGRAMS TO PROVIDE EDUCATION TO THE WORLD WIDE LUNG CANCER COMMUNITY REGARDING THE LATEST ADVANCES IN LUNG CANCER TREATMENT.
MEETING AND WEB SEMINARS TO DISSEMINATE INFORMATION REGARDING THE LATEST ADVANCES IN LUNG CANCER TREATMENT.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Heather Wakelee MD President | Trustee | 10 | $0 |
Erik Thunnissen MD Treasurer | Trustee | 10 | $0 |
Tetsuya Mitsudomi MD PHD Past President | Trustee | 10 | $0 |
Paul Van Schil MD President Elect | Trustee | 10 | $0 |
Young Tae Kim MD PHD Director | Trustee | 3 | $0 |
Joachim Aerts MD PHD Director | Trustee | 3 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
International Conference Services Conference Management Fees & Other | 12/30/22 | $3,855,206 |
Cancer Research & Biostatistics Staging Project Labor, Supplies & Other | 12/30/22 | $1,010,129 |
999 Office Llc Rent Expenses And Parking | 12/30/22 | $403,013 |
Reed Messe Wien Gmbh Conference Venue | 12/30/22 | $480,036 |
Elsevier Jto Publisher | 12/30/22 | $282,054 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $667,983 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $122,614 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $790,597 |
| Total Program Service Revenue | $16,694,390 |
| Investment income | $210,228 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $8,672 |
| Net Gain/Loss on Asset Sales | -$6,052,389 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $11,551,380 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $539,836 |
| Compensation of current officers, directors, key employees. | $539,836 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $2,957,452 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $24,508 |
| Fees for services: Accounting | $49,350 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $462,981 |
| Advertising and promotion | $0 |
| Office expenses | $331,926 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $205,185 |
| Travel | $134,715 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $6,719,850 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $355,905 |
| Insurance | $0 |
| All other expenses | $120,090 |
| Total functional expenses | $14,627,829 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $623,432 |
| Savings and temporary cash investments | $7,842,263 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $4,783,308 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $1,875,986 |
| Net Land, buildings, and equipment | $947,172 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $8,178,483 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $1,131,251 |
| Total assets | $25,381,895 |
| Accounts payable and accrued expenses | $1,397,094 |
| Grants payable | $0 |
| Deferred revenue | $7,842,263 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $958,620 |
| Total liabilities | $10,197,977 |
| Net assets without donor restrictions | $15,183,918 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $25,381,895 |
Grants Awarded
Over the last fiscal year, International Association For The Study Of Lung Cancer has awarded $335,000 in support to 5 organizations.
| Grant Recipient | Amount |
|---|---|
JOHNS HOPKINS UNIVERSITY PURPOSE: SUPPORT DEVELOPMENT OF RESEARCH & YOUNG MEDICAL PROFS. IN THORACIC ONCOLOGY. | $177,500 |
FRED HUTCHINSON CANCER RESEARCH CENTER PURPOSE: SUPPORT DEVELOPMENT OF RESEARCH & YOUNG MEDICAL PROFS. IN THORACIC ONCOLOGY. | $50,000 |
UNIVERSITY OF COLORADO DENVER - ANSCHUTZ MEDICAL CAMPUS PURPOSE: SUPPORT DEVELOPMENT OF RESEARCH & YOUNG MEDICAL PROFS. IN THORACIC ONCOLOGY. | $62,500 |
UT SOUTHWESTERN CASH MANAGEMENT PURPOSE: SUPPORT DEVELOPMENT OF RESEARCH & YOUNG MEDICAL PROFS. IN THORACIC ONCOLOGY. | $20,000 |
MD ANDERSON CANCER CENTER PURPOSE: SUPPORT DEVELOPMENT OF RESEARCH & YOUNG MEDICAL PROFS. IN THORACIC ONCOLOGY. | $25,000 |